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Abstract 
Parkinson’s Disease (PD) involves the degeneration of dopaminergic (DA) neurons in the 
substantia nigra pars compacta (SNc) that is thought to cause the classical motor symptoms of this 
disease. However, motivational and affective impairments are also often observed in PD patients. 
These are usually attributed to a psychological reaction to the general motor impairment and to a loss 
of some of the neurons within the ventral tegmental area (VTA). We induced selective lesions of the 
VTA and SNc DA neurons that did not provoke motor deficits, and showed that bilateral dopamine 
loss within the SNc, but not within the VTA, induces motivational deficits and affective impairments that 
mimicked the symptoms of PD patients. Thus, motivational and affective deficits are a core impairment 
of PD, as they stem from the loss of the major group of neurons that degenerates in this disease (DA 
SNc neurons) and are independent of motor deficits.  
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Main text: 
 
Parkinson’s disease (PD) is mainly characterized by a progressive degeneration of midbrain 
dopaminergic (DA) neurons along a caudorostral and lateromedial gradient, with a marked loss of 
neurons in the substantia nigra pars compacta (SNc)1, projecting to the dorsal striatum along the 
nigrostriatal pathway2, and a more modest loss in the ventral tegmental area (VTA)1, projecting to 
limbic and cortical areas along the mesolimbic and mesocortical pathways2, respectively. 
In addition to the classical motor symptoms, several neuropsychiatric symptoms, such as 
depression, anxiety and motivational deficits (apathy), are frequently observed in PD patients3, 4. The 
underlying pathological mechanisms have not yet been elucidated, but these motivational and 
affective impairments are generally attributed to the patient’s psychological reaction to the profound 
motor deficit and to the associated loss of dopaminergic neurons in the VTA4, 5. This 
pathophysiological concept stems from a dichotomous vision of the functional role of mesencephalic 
DA neurons, in which motor function is attributed to the nigrostriatal system, originating from the SNc, 
and motivational and affective functions are attributed to the mesocorticolimbic system, originating 
from the VTA2, 6, 7. 
Most of the data that have been used to ground this dichotomous vision of VTA-SNc neurons 
implication in PD symptoms have been generated using lesions of these neurons, involving various 
degrees of destruction of bordering zone of the VTA and SNc. Therefore, large SNc lesions inducing 
profound motor deficits also involve the lateral part of the VTA. Conversely, the VTA lesions used to 
attribute motivational properties to this structure always involve destruction of the medial part of the 
SNc6, 8. Consequently, the origins of the motivational symptoms in PD remain unresolved, not least 
because disentangling the potential motivational and mood-related deficit alterations from motor 
impairments remains a challenging issue in animal models of PD9. 
We have developed a lesional model, based on the stereotaxic injection of the 
catecholaminergic neurotoxin 6-hydroxydopamine (6-OHDA) into precise areas of the rat brain, in 
which degenerations of the DA mesocorticolimbic and nigrostriatal systems can be clearly separated 
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and in which the motor skills of the animals are preserved. We evaluated several aspects of behavior 
and found that bilateral dopamine loss within the SNc, but not within the VTA, caused motivational 
deficits and affective impairments resembling some of the neuropsychiatric symptoms observed in PD 
patients.  
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Results 
 
Bilateral partial lesions of the mVTA or SNc result in distinct, non overlapping, complementary 
patterns of DA denervation 
mVTA  and SNc lesions produce two distinct, non overlapping, complementary, patterns of bilateral 
DA denervation throughout the striatum, as revealed by decreases in tyrosine hydroxylase (TH)-
immunoreactivity (IR) and striatal DA contents (Fig. 1 and Fig. S1). The mVTA lesions preferentially 
affected the ventral part of the striatum, resulting in a 40 to 60% decrease in TH-IR density within the 
nucleus accumbens. The extent of the mVTA lesions therefore mimicked the loss of dopaminergic 
innervation observed in the ventral head of the caudate nucleus in PD patients10. The SNc lesion was 
associated with a similar decrease in TH-IR density, along the rostrocaudal extent of the dorsal 
striatum, predominantly in its lateral portion (~70%). 
 
Bilateral partial DA lesions of the mVTA or SNc do not induce locomotor deficits 
 As expected with such partial striatal DA denervation11, neither SNc nor mVTA lesions impaired 
sensorimotor coordination on an accelerating rotarod or spontaneous locomotor activity (Fig. 2A, B). 
Furthermore, despite a slight alteration of stepping adjustment in SNc DA-lesioned rats (Fig. 2C), no 
impairment was observed with regards to fine-motor velocity or ambulatory coordination in an 
automated laboratory gait analysis system (Fig. 2D). 
 
Bilateral partial DA lesions of the SNc, but not of the mVTA, decrease general behavioral 
activity 
The lack of a major motor deficit after partial lesioning of the SNc allowed us to study specifically the 
role of the DA nigrostriatal system in motivational processes, in the absence of the usual potential bias 
related to locomotor alterations. Apathy is one of the major non motor symptoms of PD3, 4. Apathy is 
defined as a lack of motivation, or a reduction in “goal-directed behaviors”12, with a global deficit in self-
initiation and maintenance of voluntary and purposeful behavior, resulting in low levels of activity and a 
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loss of interest in sources of reinforcement13-15. Interestingly, the mVTA lesions had no significant effect 
on general consummatory responses, measured as water and food intake over a 24-hour period, 
whereas SNc lesions decreased these behaviors (Fig. 3A and B) and were associated with a slower 
weight gain (Fig. 3C), sometimes associated with a transient starvation state after surgery (see online 
Methods). Like apathetic patients12, 13, rats with DA lesions of the SNc, but not of the mVTA, displayed 
a decrease in social interaction (Fig. 3D) that could not be attributed to an olfactory deficit, since neither 
attraction to an appetitive odor (coconut, Fig. 3E) nor avoidance from an aversive (acetic acid, Fig. 3F) 
odor was altered by the DA lesions. 
 
Bilateral partial DA lesions of the SNc, but not of the mVTA, specifically impair motivated 
behaviors 
 This aspect of behavior was investigated further, in various non operant and operant tasks, including 
place preference, instrumental responding and runway tasks for palatable food. The use of this 
approach made it possible to distinguish between the effects of the lesion on preparatory and 
consummatory components of motivated behaviors. Specifically, the acquisition of a runway task 
(progressive reduction in the latency to reach and to start to eat a palatable food at the end of a 
straight alley) was similar in all conditions, demonstrating an absence of learning deficits (Fig. 4A). 
However, SNc DA lesions decreased asymptotic performance, essentially due to a greater number of 
interruptions and route reversals in SNc-lesioned than in sham rats, resulting in a smaller number of 
direct runs to the goal (Fig. 4A). These observations are consistent with a weaker motivation to reach 
the goal16 or an approach/avoidance conflict17, that cannot be attributed to deficits in Pavlovian 
associative processes or in the reinforcing properties of the palatable food, as neither type of lesion 
affected performance in conditioning place preference (CPP) for the same food (Fig. 4B). 
 An effect of SNc lesion on preparatory behavior was further demonstrated by a dramatic 
impairment of instrumental responding for a sucrose solution in SNc lesioned rats as compared to 
both sham and mVTA lesioned rats (Fig. 4C and S3A-B), the latter even tending to outperform 
controls, both during acquisition and when the workload required to obtain the reward increased 
exponentially under a progressive ratio schedule of reinforcement, an index of motivation18 (Fig. S3C). 
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The reduced behavioral responses of SNc-lesioned rats cannot be attributed to an impairment in 
instrumental learning, as their capacities to discriminate between the active and inactive (control) lever 
throughout the task were preserved (Fig. S3B), or to a decrease in sensitivity to the motivational 
properties of sucrose, as demonstrated by their clear preference for the same sucrose solution in a 
two-bottle choice procedure (Fig. 4D and S4A). Similar results were obtained with saccharin, a non 
caloric sweetener (Fig. S4B), excluding an effect of potential metabolic confounding factors. In this test, 
lesioned animals were also able to differentiate between two saccharin concentrations and to shift their 
preference toward the concentration supplying the greatest reward (Fig. S4C). Thus, the poorer 
operant performances of the SNc lesioned animals do not result from a learning deficit or a change in 
reward or hedonic processing. Instead, they reflect a profound decrease in motivation to work to obtain 
the reward. 
 This deficit in the motivational preparatory responding also affects novelty-seeking, 
operationalized by the acquisition of instrumental conditioning reinforced only by contingent 
presentations of a “novel” cue-light19. As shown on Fig. 4E, this cue-light acted as a robust positive 
reinforcer in both sham groups and mVTA-lesioned rats, but not in SNc-lesioned animals. This result is 
of particular interest because neither mVTA nor SNc lesions impaired preference for a novel 
environment in a non instrumental novelty preference procedure (Fig. 4F), thereby suggesting that 
interest for novelty was unaffected. Again, a marked motivational deficit was observed specifically in 
animals with SNc DA lesions, when an instrumental preparatory action was required. 
 These between-subject differences specific to the SNc lesioned rats were further supported by 
dimensional analyses. Thus, whereas linear regression analyses yielded no significant 
correlations in the runway (data not shown), robust negative correlations were found 
between operant performances in the sucrose (Figure 4C) and cue-light self-administration 
procedure (Figure 4E) and the loss of TH immunoreactivity within the dorsal striatum for the 
SNc group. Interestingly, these correlations were not found within the NAc for the VTA group. 
These data therefore strengthen the implication of nigrostriatal DA in motivated behaviors. 
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Bilateral partial DA lesions of the SNc, but not of the mVTA, induce depressive and anxiety-
related behaviors 
This generalized lack of motivation seems to present face validity with regards to the pathophysiology 
of PD, which is frequently accompanied by mood disorders related to DA denervation, including 
depression and anxiety3-5. Consistent with observations in humans, SNc-lesioned rats also displayed a 
depressive-like behavior, as revealed by an increase in the time they spent immobile in the forced-
swim test, whereas no such effect was observed in mVTA-lesioned rats (Fig. 5A and S5A). Similarly, 
anxiety-related behaviors, reflected by a reduced latency to enter in the dark side of a light/dark 
apparatus (Fig. 5B and S5B) and a decreased time spent in the open arms of an elevated plus-maze 
(Fig. 5C and S5C), were seen in SNc-, but not mVTA-lesioned animals. Therefore, only SNc DA 
lesions affected mood-related behaviors. 
 For these affective-related behaviors, a significant negative correlation was found 
between the latency to enter into the dark chamber in the light/dark avoidance test and loss 
of TH immunoreactivity within the dorsal striatum (Figure 5B) suggesting that the observed 
increase in anxiety is related to the degree of striatal dopamine depletion. However, no 
similar correlations were found in the elevated plus-maze and the forced-swim test (Figure 
5A,C).  
 
Reversion of the behavioral deficits resulting from nigrostriatal DA denervation by 
pharmacological DA agents 
To further investigate the role of DA and validate our experimental approach, we tested whether 
subchronic administration of pharmacological DA agents classically used in PD could reverse some of 
the behavioral impairments induced by SNc lesions. The depressive- and anxiety-like behaviors 
displayed by SNc-lesioned rats were reversed by the D2/D3 agonist ropinirole and by L-dopa (Fig. 6A-
B and S6A-B). Both pharmacological DA agents have been shown to have beneficial effects on 
apathetic symptoms and mood in PD3, 15. These findings thereby provide an interesting predictive 
validity for this model, in terms of the causal implication of DA. In addition, ropinirole clearly improved 
motivated behaviors of SNc-lesioned rats, in an operant sucrose self-administration procedure (Fig. 
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6C and S6C-D). The selective serotonin reuptake inhibitor (SSRI) citalopram had no effect on 
motivated and depressive-like behaviors in lesioned animals (Fig. 6A and C, and S6), consistent with a 
selective role for DA, although the effect of this drug on anxiety-like behaviors (Fig. 6B) suggests a 
possible interaction with the serotoninergic system. 
Drui et al., 2012 
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Discussion 
This study provides new insights into the pathophysiological mechanisms underlying the 
neuropsychiatric symptoms of PD. Indeed, our data clearly demonstrate that selective bilateral and 
partial lesions of the SNc, but not of the mVTA, induce a profound deficit in motivated behaviors and 
related affective changes. These behavioral deficits were selectively reversed by L-dopa and by the 
direct activation of the D2/D3 receptors with ropinirole, confirming the critical role played by DA. 
Studying the non motor functions of the DA nigrostriatal system has remained a critical issue, 
due to the potential influence of motors deficits on the behavioral performances of the animals and the 
difficulty of targeting this pathway specifically. For example, large lesions of the DA nigrostriatal system 
and genetically-induced complete DA depletion lead to the so-called “lateral hypothalamic syndrome”, 
characterized by a dramatic aphagic and adipsic state6, 20, 21, a phenotype in some ways similar to the 
decrease in consummatory responses we observed in SNc-lesioned animals. However, it was not 
clear whether these impairments resulted from a pure motivational deficit or from the strong akinesia 
induced by the lesion, and whether they were specific to the nigrostriatal system. Similarly, previous 
studies attempting to model cognitive dysfunctions and neuropsychiatric symptoms in PD with 
unilateral or bilateral 6-OHDA lesions in rats or MPTP-lesioned monkeys, have rarely been able to 
circumvent possible motor confounding factors and did not systematically aim to target the DA 
nigrostriatal system selectively9, 22, 23. In the present study, with the use of partial and bilateral DA 
denervation, we were able to disentangle the non motor from the motor function, an approach that 
was further confirmed by the lack of specific relationship between individuals presenting no or mild 
motor deficits and their behavioral performances (data not shown). Thus, the lack of effect of the 6-
OHDA lesions on several aspects of sensorimotor and ambulatory behavior suggests that motor 
alterations cannot account for the strong phenotype associated with partial DA denervation of the 
nigrostriatal system evidenced in this study.  
These results therefore clearly demonstrate that selective bilateral lesions of the SNc, but not 
of the mVTA, induce a profound deficit in motivated and affective-related behaviors. While the lack of a 
robust correlation between affective-related deficits and dorsal striatum DA depletion suggests a 
potential role of extra-striatal regions receiving DA inputs from the SNc such as the amygdala or the 
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orbitofrontal cortex2 in such behaviors, the clear-cut correlation between deficits in operant 
performances and the degree of TH loss in the dorsal striatum univocally emphasizes the predominant 
role of the DA nigrostriatal system in specific motivational processes.  This result is particularly striking 
as, by contrast, a partial DA lesion of the mVTA, an area known to be involved in reinforcement and 
motivational processes6, 24-26, did not modify any of the non motor behaviors evaluated here. 
Interestingly, sensitivity to reward and Pavlovian processes, which are dependent on the DA 
mesocorticolimbic system24, 26, were unaffected by the lesion, which seems to alter the preparatory 
aspect of instrumental responses in a specific manner. Consistent with these findings, the SNc is 
located at the interface between the neurobiological systems underlying goal-directed and habitual 
control of behavior24, 27, 28, where DA neurons encode crucial motivational and reward-related signals30. 
The lesion generated is therefore likely to strongly interfere with the chain of processes that increase 
motivation and energize actions for a specific goal. 
The behavioral phenotype induced by the SNc DA lesion is also reminiscent of apathy and 
related neuropsychiatric symptoms observed in PD patients4, 5, suggesting that the DA nigrostriatal 
system plays a primary role in non motor deficits in PD. It has been suggested that apathy in PD may 
result from a corticostriatal dysfunction linked to the loss of nigrostriatal DA tone13. Furthermore, a 
recent study using an implicit incentive task14 reported an association of apathy in PD and non PD 
patients with changes in the motivational processes normally responsible for translating expected 
reward into effort and action, with no change in the perception of reward value. These findings are 
therefore strikingly similar to the motivational deficits observed in our experimental model and its 
underlying neurobiological substrate. 
 The adverse phenotype induced by the SNc lesion is reversed, at least partly, by 
pharmacological DA agents known to have positive effects on apathetic symptoms and mood in PD3, 
15. While both L-dopa and ropinirole completely reversed depressive- and anxiety-related behaviors, 
only ropinirole significantly improved motivated behaviors in lesioned animals. This may reflect the 
differences in the pharmacological properties of the two DA drugs, with L-dopa acting presynaptically 
on a denervated system and ropinirole having a stronger effect through the direct activation of 
Drui et al., 2012 
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postsynaptic receptors, including, in particular, the D3 receptor, a potent regulator of mood and 
motivated behaviors29. Indeed, it has been suggested that D2/D3 agonists such as ropinirole, may be 
more effective than other DA agents for the treatment of apathy, due to their high affinity for D2 and D3 
receptors3, 15. By contrast, the SSRI citalopram had no beneficial effect on motivated and depressive-
like behaviors, consistent with several clinical observations suggesting that SSRIs are much less 
effective than DA agonists for reducing depressive symptoms in PD30, 31 and may even have a 
deleterious effect on apathy32. These data strengthen the validity of our experimental approach in 
regard to PD-related neuropsychiatric symptoms and the critical role of DA. 
The effect of citalopram on anxiety-related behaviors indicates however a possible implication 
of the serotoninergic system. Electrophysiological and neurochemical studies have reported a strong 
interaction between the dopaminergic and serotoninergic systems, with a prominent modulation of 
midbrain DA neuronal activity by the raphe nuclei33. Moreover, complex interactions between the 
serotoninergic and dopaminergic system has been reported in PD34 and related animal models35. 
Such interactions may account for the complex influence of serotonin on the DA dysfunction 
highlighted by the present data. 
In conclusion, this study highlights a critical role in motivation for the SNc that had been 
previously largely neglected and attributed to the DA mesoaccumbal pathway2, 27. These data also 
demonstrate that motivational and affective deficits are a core impairment of PD, independent of the 
motor deficits and resulting from the loss of the major neuronal group known to degenerate in this 
disease (DA SNc neurons). This new insight into the pathophysiological mechanisms of mood and 
motivational dysfunctions in PD will facilitate the design of new treatments through a more balanced 
approach taking into account the entire spectrum of deficits observed in this brain disease.  
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Figure legends 
 
Fig. 1. Bilateral partial lesions of the mVTA or SNc result in distinct, non overlapping, 
complementary patterns of DA depletion throughout striatal territories. (A and B) 
Representative photomicrographs of coronal sections stained for TH in striatal (+1.7 to 0.7 mm 
anterior to bregma) (A) and mesencephalic (-5 to -5.8 mm anterior to bregma) (B) regions according to 
the stereotaxic atlas of Paxinos and Watson36, 37.  Bar = 1 mm. The intensity of the gradient of color 
(white to green or white to blue) in schematic sections corresponds to the measured DA lesioned area 
in the different brain structures studied for each lesion performed. mVTA lesion are shown in green 
and SNc lesion in blue. The highest intensity of green or of blue color (100%) indicates that all animals 
had lesions in the corresponding area, whereas the lowest color intensity (white, 0%) corresponds to a 
non lesioned or denervated area. (C and D) Quantification of the loss of TH staining in the different 
mesencephalic (C) and striatal (D) structures, expressed as percentage of the mean value obtained 
for sham-operated animals. Two-way ANOVAs revealed significant interactions between the lesion 
and the brain region considered (Fs > 9.49, Ps < 0.001). n = 22-28, *P < 0.05, **P < 0.01, ***P < 
0.001. mVTA, medial ventral tegmental area; NAc, nucleus accumbens; SNc, substantia nigra pars 
compacta.  
 
Fig. 2. Bilateral partial 6-OHDA lesions of either the mVTA or SNc do not impair locomotion. (A, 
B) DA lesions did not affect the latency to fall from an accelerating rotarod (A) (Ps > 0.42, n = 22-28), 
or horizontal ambulatory activity (B) during a 20 minutes period in an open area (no effect of lesion: Fs 
< 0.91, Ps > 0.35 and no lesion x time interaction: FS < 0.64, Ps > 0.88, n = 11-18). (C) A two-way 
ANOVA showed a marginal effect of the SNc lesions (F1,144 = 4.04, P = 0.05) and lesion x paw 
interaction (F3,144 = 2.54, P = 0.06) on the number of adjusting steps. No such effects were found for 
the mVTA lesions (Fs < 1.91, Ps > 0.18), n = 22-28. (D) SNc lesions had no effect on gait parameters 
analyzed with an automated gait analysis system (no effect of lesion: Fs < 2.37, Ps > 0.14 and no 
lesion x paw interaction: Fs < 0.92, Ps > 0.43, n = 12-14). 
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Fig. 3. Bilateral partial 6-OHDA lesions of the SNc, but not of the mVTA, decrease 
consummatory responses, weight gain and social interaction without affecting olfaction. (A, B) 
Water (A) and food (B) intake in the homecage were measured over a 24-hour period. (B) Both 
lesions resulted in a loss of weight after surgery, but mVTA-lesioned animals recovered during the 
three weeks following surgery, whereas SNc-lesioned animals continued to gain less weight than the 
controls (Effects of lesion: Fs > 4.48, Ps < 0.05 and significant lesion x day interaction: Fs > 5.16, Ps < 
0.001). (D) SNc lesions reduced the time spent in social interaction with a congener. (E, F) 6-OHDA 
lesions did not affect attraction toward an appetitive (coconut, E) or avoidance from an aversive (acetic 
acid, F) odor n = 12-18. *P < 0.05, **P < 0.01, ***P < 0.001, Sham-operated vs. Lesioned. 
 
Fig. 4. Bilateral partial 6-OHDA lesions of the SNc, but not of the mVTA, impair motivated 
behaviors. (A, B) SNc (lesion x session interaction: F6,108 = 2.65, P < 0.02, n = 19-22) but not mVTA 
(lesion x session interaction: F6,66 = 0.84, P = 0.55, n = 12-15) lesions increased the latency to reach a 
palatable food in a runway paradigm at the asymptotic level (A), with no incidence on CPP for the 
same reward (B, effect of conditioning: FS  > 11.61, Ps < 0.001, no effect of lesion: FS  < 0.50, Ps > 0.48 
and no interaction: FS  < 0.16, Ps > 0.69, n = 10-17). (C, D) SNc (*P < 0.05) but not mVTA (P = 0.41) 
lesions decreased operant sucrose self-administration (C, representation of the mean of the three last 
FR1 sessions (first graph) and linear regressions between sucrose deliveries and the loss of TH in the 
NAc (second graph) and the dorsal striatum (third graph) for mVTA and SNc lesions respectively, n = 
6-9), while having no significant effect on sucrose preference in a two-bottle choice procedure (D, Ps > 
0.08, n = 12-19).  (E) SNc but not mVTA lesions (Effect of lesion: F1,98 = 14.1, P < 0.01 and F1,91  = 0.01, 
P = 0.94 respectively, n = 7-8) reduced self-activation of a cue-light during an operant procedure. 
Linear regressions between cue-light deliveries and the loss of TH in the NAc and the dorsal striatum 
for mVTA and SNc lesions respectively. (F) No effects of the 6-OHDA lesions were found on the 
preference for a novel environment (Ps > 0.73), n = 6-8.*P < 0.05, **P < 0.01, Sham-operated vs. 
Lesioned. 
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Fig. 5. Bilateral partial 6-OHDA lesions of the SNc, but not of the mVTA, cause a broad 
spectrum of affective impairments. (A-C) SNc-lesioned rats displayed increased immobility in the 
forced-swim test (A, effect of lesion: (F1,47 = 4.71, p < 0.05), no effect of site: (F1,47 < 1) and a 
significant interaction between both factors: (F1,47 = 4.15, p < 0.05, n = 12-19), and anxiety-like 
behaviors, as reflected by a reduction in the latency to enter into the black compartment in a light/dark 
avoidance test (B, effect of lesion: (F1,59 = 4.73, p < 0.05), no effect of site: (F1,59 < 1) and no 
significant interaction: (F1,59 = 2.07, p = 0.15, n = 12-19) and in the time spent in the open arms of 
an elevated plus-maze (C, marginal effect of the lesion: (F1,71 = 3.79, p = 0.06), no effect of site: 
(F1,71 = 0.06, p = 0.80), but a significant interaction between both factors: (F1,71 = 4.37, p < 
0.05), n = 15-22). No significant linear regressions were found in the forced-swim test (A) and 
in the elevated plus-maze (C) while a significant negative correlation was found between the 
latency to enter into the dark chamber in the light/dark avoidance test and loss of TH within 
the dorsal striatum (B). **P < 0.01, Sham-operated vs. Lesioned. 
 
Fig. 6. Effects of L-dopa, ropinirole and citalopram on the behavioral changes induced by the 
SNc DA lesion. Effects of chronic intraperitoneal administration of L-dopa (12.5 mg/kg), ropinirole (1 
mg/kg) or citalopram (10 mg/kg) evaluated in the forced-swim test, (A) the elevated plus-maze and (B) 
in an operant sucrose self-administration procedure (C). Significant lesion x treatment interactions 
were found for (A) and (B) (Fs > 2.94, Ps < 0.05) but not for (C) (significant effect of lesion: F1,63 = 
16.53, P < 0.001, but no interaction: F3,63 = 0.78, P = 0.51). n = 6-11. *P < 0.05, **P < 0.01, ***P < 
0.001, Sham-operated vs. Lesioned. 
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Online Methods 
Animals 
Experiments were performed on male Sprague Dawley rats (Janvier, Le Genest-Saint-Isle, France) 
weighing 180 g (6 weeks old) at the time of surgery. Animals were housed four per cage until the 
second week after surgery and then transferred to individual cages until the end of the study, under 
standard laboratory conditions (12 h light/dark cycle, with lights on at 7:00 am) with food and water 
available ad libitum, unless otherwise stated. Protocols used complied with the European Community 
Council Directive of 24 November 1986 (86/609/EEC) for the care of laboratory animals, French 
Ministry of Agriculture regulations (authorization no. 38-R1001) and French guidelines for the use of 
living animals in scientific investigations. They were approved by the Grenoble-Institut des 
Neurosciences ethics committee, under agreement number 004. 
 
Bilateral 6-OHDA lesions 
All animals were anesthetized with a mixture of xylazine (15 mg/kg i.p.) and ketamine (100 mg/kg, i.p.) 
and treated with desipramine hydrochloride (25 mg/kg s.c.; Sigma, St Quentin-Fallavier, France) to 
protect noradrenergic neurons38, 30 min before 6-OHDA injection. Rats were secured in a Kopf 
stereotaxic apparatus (Phymep, Paris, France) and 6 µg of 6-OHDA dissolved in 2.3 µl of sterile 0.9% 
NaCl with 0.2% ascorbic acid (Sigma, St Quentin-Fallavier, France) were injected bilaterally, at a flow 
rate of 0.5 µl/min. The solution was delivered to the medial plane, to target the medial ventral 
tegmental area (mVTA group), or into the medial part of the substantia nigra pars compacta (SNc 
group). The stereotaxic coordinates of the injection site relative to bregma were as follows, according 
to the stereotaxic atlas of Paxinos and Watson (1998)36: (1) mVTA lesion: anteroposterior (AP), -
5.6 mm; lateral (L), +1.0 mm, with a 10° angle toward the midline, and dorsoventral (DV), -8.1 mm; (2) 
SNc lesion: AP, -5.4 mm; L, ±1.8 mm and DV, -8.1 mm, with the incisor bar at +3.2 mm below the 
interaural plane. After each injection, the cannula was left in position for 5 min to allow the injected 
solution to be absorbed and to minimize the spread of the toxin along the needle tract. An identical 
procedure was used for sham-operated controls, but with 2.3 µl of vehicle (0.9% NaCl, 0.02% ascorbic 
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acid). After recovery from anesthesia, animals returned to the facility for three weeks, to allow the 6-
OHDA lesion to develop and stabilize38, before the beginning of the behavioral experiments. 
Transient starvation states occurred two to three days after surgery in a subset of SNc-lesioned 
animals (around 20%). These animals received supplementation with a high-caloric liquid diet and 
palatable food for 1 to 2 weeks. Animals that did not recover (< 5%) were discarded from the 
experimental procedure. This phenotype was never observed in the Sham and mVTA lesions groups. 
 
Histological analysis 
Immunohistochemistry. Immunohistochemical analysis was carried out as previously described39. 
Briefly, rats were killed under chloral hydrate anesthesia at the end of the behavioral experiments, 
perfused intracardially with paraformaldehyde and brains removed. Free-floating 30 µm-thick coronal 
sections from the mesencephalon and the striatum were incubated with an anti-TH antibody (mouse 
monoclonal MAB5280, Chemicon, Temecula, USA; 1:2500), and then with a biotinylated goat anti-
mouse IgG antibody (BA-9200, Vector Laboratories, Burlingame, CA, USA; 1:500). Immunoreactivity 
was visualized with avidin-peroxidase conjugate (Vectastain ABC Elite, Vector Laboratories, 
Burlingame, CA, USA).  
 
Quantification of the extent of the mesencephalic DA lesion and of striatal DA denervation. 
TH-immunolabelling detection of DA neurons and terminals were evaluated under a light microscope 
(Nikon, Eclipse 80i) coupled to the ICS FrameWork computerized image analysis system (TRIBVN, 
2.9.2 version, Châtillon, France).  
For quantification, six selected TH-labeled coronal sections for each experimental animal, 
corresponding to three antero-posterior levels of the striatum (+0,7 to 1.7 mm anterior to bregma) and 
of the mesencephalon (-5 to -5.8  mm anterior to bregma), were digitized with a camera (Pike F-421C, 
ALLIED Vision Technologies, Stadtroda, Germany). For each section, six subregions within the 
striatum and three subregions within the mesencephalon were chosen, taking into account the 
topography of DA innervation2, 40, as indicated in Fig. S1A and B. 
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For all quantitative measurements, masks from these different striatal and mesencephalic subregions 
were drawn with the computer analysis system to ensure that appropriate comparisons were made 
between homologous anatomical regions. Optical densities (OD) were measured for each striatal and 
mesencephalic subregion, and the mean OD was calculated with ICS FrameWork software (TRIBVN, 
2.9.2 version, Châtillon, France). OD values were measured for the denervated and non denervated 
territories of the lesioned animals for each section analyzed and were compared with those for the 
homologous regions in sham-operated animals. The OD value obtained for an unlabeled area (the 
corpus callosum) was used as the background and was subtracted from each of the OD values 
measured.  
A simplified and classic subdivision of mesencephalic and striatal areas is shown in Fig. 1, for 
conciseness and to take the nigrostriatal and mesolimbic projections into account. 
 
Brain tissue dopamine determination 
Three weeks after surgery, dorsal striatum and NAc were dissected out and processed as previously 
described41, for the determination of DA concentration with a liquid chromatography system 
(Shimadzu, France) coupled to an electrochemical detector (Decade, Antec Leiden, the Netherlands) 
and a C18 reverse-phase microcolumn (Aquasil, RP-18, 150×1 mm, 3 µm particle size, 
ThermoHypersil, maintained at 30°C). The mobile phase (50 mM NaH2PO4, 0.1 mM EDTA-Na2, 1.7 
mM sodium octyl sulfate, 4.5 mM KCl and 5% acetonitrile (vol/vol), adjusted to pH 3.10) was run at a 
flow rate of 0.06 ml/min. DA contents were determined by comparing DA peaks with external 
standards and were expressed as the amount of DA, in ng per mg of brain tissue. 
 
Behavioral procedures  
All rats were subjected to a sequence of behavioral tests, as summarized in Fig. S2. Different groups 
of animals were exposed to different sequences, as some combinations of tests, such as operant 
sucrose self-administration and cue-light self-administration or conditioned place preference (CPP) 
and novelty-preference, could not be performed on the same animal. However, all animals were 
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tested for potential locomotor deficits on the rotarod and in the stepping test. When animals were 
subjected to a long sequence of behavioral tests or pharmacological treatment, two subgroups of 
animals were constituted, and the order of the tests was reversed in the second subgroup (see group 
A and B in Fig. S3A and B), to ensure that the effects of the lesion or of a pharmacological treatment 
did not change over the course of the study. No effect of order was found, in any of the conditions 
tested (data not shown). In each experiment, all conditions (lesions and/or pharmacological 
treatments) were counterbalanced among the different test chambers according to a Latin-square 
design. Each apparatus was cleaned with 10% ethanol and 2% H2O2, and dried with a paper towel 
after each trial or session. 
 
Accelerating rotarod. Animals were first trained to remain on a rotarod (Harvard Apparatus, Holliston, 
MA, USA) turning at 4 rpm for more than 30 s. The rotation speed of the rod was then gradually 
increased, at a rate of 1 rpm every 8 s. Latency to fall from the rod was recorded three times for each 
rat. 
 
Stepping test. Animals were moved sideways along a smooth-surfaced table number of forelimb 
adjusting steps measured, as described by Olsson et al., 199542. The test was carried out three times 
for each paw, by two experimenters blind to the experimental conditions. 
 
Gait analysis. Gait was analyzed with an automated gait analysis system (GaitLab, Viewpoint S.A., 
Champagne au Mont d'Or, France). Rats were imaged from below, with a high-speed camera (~150 
frames per second), while they ran on a narrow glass corridor (7 × 90 cm), to identify paw step 
positions and moving speed. Different metrics were calculated, including speed, stride length, stance 
time, swing time and number of strides per second. After a period of training of one week, gait and 
ambulatory behaviors were recorded three times for each rat, on a final test day. 
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Locomotor activity. Rats were placed in a dimly lit white Perspex™ open arena (50×50×40 cm) and 
horizontal distances traveled were recorded with a video-tracking system (Viewpoint S.A., 
Champagne au Mont d'Or, France), over a 20-minute period. 
 
Olfactory tests. Tests were carried out in a dimly lit white open arena, with a video-tracking system. 
Olfactory avoidance and preference behaviors were evaluated by comparing the time the rats spent 
near two filter papers soaked in 40% acetic acid or in 50% coconut milk with the time spent near two 
filter papers soaked in distilled water. Acetic acid and coconut milk were used as they have been 
shown to be potent olfactory aversive43 and attractive44 cues, respectively. 
 
Runway task for food. Food-restricted rats (90% of their free-feeding weight) were trained to run from 
a start box (20x15x40 cm) to the end of a Perspex™ alley (100x15x40 cm) to obtained a palatable 
food (salted, cheese-flavor cookies, Belin, France) presented in a plastic bowl. Ambulatory pattern was 
recorded, together with the latency to reach the food at the end of the runway and to start to eat it, with 
a video-tracking system. Animals were allowed to eat for less than 30 s, to prevent early satiation16. A 
120 s cut off was used when animals did not complete the task. This procedure was repeated three 
times per day over a period of seven days. Performances were represented as a completion score16:  
(120 – latency to reach food)/120 x 100. 
 
Conditioned place preference for food. CPP chambers consisted of two compartments (40x33x35 
cm) differing in wall colors and floor texture, separated by a small (10 cm length) compartment45. A 
video-tracking system was used to measure the time spent in each compartment. During a 
preconditioning session, food-restricted rats (90% of their free-feeding weight) were placed in the CPP 
chamber and allowed to freely explore the three compartments for 15 minutes. Conditioning took 
place over eight consecutive days. During these sessions, animals were confined alternatively to one 
compartment with palatable food (Belin, France) for the paired condition, or without food for the 
unpaired condition, and to the other without food for both the paired and unpaired conditions. For 
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testing, rats were allowed to explore the entire chamber for 15 minutes, as during the preconditioning 
session. Preference scores were expressed as the difference between the time spent in the food-
paired compartment during the CPP test and the preconditioning test. 
 
Evaluation of sucrose preference. Rats were given 24-h concurrent access in their home cage to 
two graduated 250 ml plastic bottles (Techniplast, France), for three days. One of these bottles 
contained tap water, whereas the other contained 2% sucrose (Sigma, St Quentin-Fallavier, France) 
in tap water. Rats and bottles were weighed daily, with the position of the bottles (left or right) 
alternated, to control for side preference. The first day was used as an acclimation period. The 
volumes of sucrose solution and water consumed on the second and third days were averaged to 
determine sucrose, water and total fluid intake (ml/kg), and preference for sucrose over water (sucrose 
intake/total intake, expressed as a percentage). 
 
Evaluation of saccharin preference. Rats were given 24-h concurrent access to a bottle containing 
tap water and another containing 0.002% saccharin (Sigma, St Quentin-Fallavier, France) in tap 
water, using a procedure similar to that for sucrose. Rats were then given access to two bottles, 
containing 0.002% and 0.02% saccharin, respectively, for the next three days. 
 
Operant sucrose self-administration. Rats were first habituated to voluntary consume 2% sucrose 
solution in a two-bottle choice procedure, as described above. They were then trained to self-
administer a 2% sucrose solution in operant chambers (Med Associates, St. Albans, VT, USA) as 
previously described46, under a fixed ratio 1 reinforcement schedule (FR1), with an active, reinforced, 
lever, for which presses resulted in the delivery of 0.2 ml of the sucrose solution, and an inactive, non 
reinforced, lever. Once performances had stabilized (less than 20% performance variation over three 
consecutive sessions), rats were subjected to a progressive ratio schedule session, in which the 
number of active lever presses required for a reward increased exponentially after each reward, 
according to Roberts’ equation47. The session ended when the rat failed to complete a response 
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requirement (i.e., a ratio) within one hour. The breakpoint was defined as the final ratio completed by 
the animal47. 
 
Cue-light self-administration. A naive set of rats (i.e., that had not been subjected to the operant 
sucrose self-administration procedure) was tested daily for 1 h, during 8 days, for lever responses to 
the contingent presentation of a 6 s cue-light (FR1), located 4 cm above the active lever, in the self-
administration chambers described above. The sides on which the inactive and active levers were 
located (right or left), were distributed evenly between the different conditions. 
 
Novelty preference. This procedure was adapted from a method described elsewhere48. We used 
the same place preference chambers as described above for the CPP for food, with the same video-
tracking system set-up. Rats were pseudorandomly exposed for 20 min to one compartment 
(‘familiar’). At the end of this habituation phase, animals were allowed to explore the whole chamber 
(familiar and new compartments) for 15 min. A novelty preference index was calculated as follows: 
time spent in the new compartment/(time spent in the new compartment + time spent in the familiar 
compartment) x 100. 
 
Social interaction. Rats were placed in a dimly lit white Perspex™ arena (50x50x45 cm), for 10 min, 
for acclimatization to their surroundings. An unfamiliar male congener was then introduced into the 
arena and social interaction was video-recorded for 10 min. The total time that the test rats spent 
engaging in social interaction behaviors (listed and defined in49) was scored by two observers blind to 
the experimental conditions. 
 
Elevated plus-maze. The elevated plus-maze (Viewpoint S.A., Champagne au Mont d'Or, France) 
consists of two opposing open arms and two opposing arms enclosed by 40 cm high walls, and was 
placed in a dimly lit room. Each arm was 50 cm long and 10 cm wide and made of black Perspex™, 
suspended 55 cm above the floor. The rats were placed in the center of the maze and their behavior 
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was recorded for 5 minutes with a video-tracking system. Number of entries into and total time spent in 
the open and closed arms were quantified by the video-tracking system. 
 
Light/dark avoidance test. The apparatus was made of Plexiglas and consisted of a light and a dark 
chamber (38x33x35 cm each), separated by an opaque Plexiglas wall with a 7 x 7 cm aperture, to 
allow the animals to move freely between the chambers. The light chamber was made of white walls, 
opened at the top, and was lit with a white incandescent light (100 watts) located 70 cm above the 
floor of the chamber. By contrast, the dark chamber was made of black walls, closed at the top, and 
was not lit. The animals were placed in the center of the light chamber, facing away from the opening 
toward the dark chamber, and were video-recorded for 5 min. Latency to the first entry into the dark 
chamber and the total amount of time spent in the light chamber were determined by two observers 
blind to the experimental conditions. 
 
Forced swim test. Rats were placed in a cylinder of 40 cm high and 20 cm in diameter, filled with 
water (24±1°C) to a depth of 30 cm, for 15 min. Twenty four hours later, they were placed in the same 
cylinder for 5 min. Animal activity was detected and recorded with a video-tracking system. 
 
Pharmacological procedures. Three weeks after 6-OHDA infusion, we initiated a sequence of 
behavioral tests on mSNc-lesioned rats, as described in Fig. S2B. Intraperitoneal administration of 
12.5 mg/kg of L-dopa (together with 15 mg/kg of benserazide), 1 mg/kg of ropinirole, 10 mg/kg of 
citalopram, or vehicle (0.9% NaCl), at a volume of 1 ml/kg, began two days before the start of the 
behavioral tests sequence. Injections were carried out 30 min before the beginning of each behavioral 
session. 
 
Data and statistical analysis 
Data were analyzed by t-tests or two-way ANOVAs, depending on the experimental design. When 
indicated, post-hoc analyses were carried out with the Bonferroni’s correction procedure or the method 
of contrasts. Dimensional analyses were performed by parametric simple linear regressions. 
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